The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Relevium Technologies's Revenue for the
three
months ended in Mar. 2022 was $1.91 Mil. Relevium Technologies's average Accounts Receivable for the
three
months ended in Mar. 2022 was $0.69 Mil.
Hence, Relevium Technologies's Receivables Turnover for the
three
months ended in Mar. 2022 was 2.75.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Relevium Technologies Receivables Turnover Related Terms
Relevium Technologies Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Relevium Technologies's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RLLVF vs HEWA, SSY: Receivables Turnover Comparison
For the Pharmaceutical Retailers subindustry, Relevium Technologies's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Relevium Technologies Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Relevium Technologies's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Relevium Technologies's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Relevium Technologies (RLLVF) has a Receivables Turnover of 2.75 as of Mar. 2022. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Relevium Technologies and its competitors.
Is Relevium Technologies' Receivables Turnover too high?
Relevium Technologies' current Receivables Turnover is 2.75. The Healthcare Providers & Services industry median Receivables Turnover is 7.69. Relevium Technologies' value of 2.75 is 64.2% below this industry median.
How does Relevium Technologies' Receivables Turnover compare to HEWA and SSY?
Relevium Technologies' Receivables Turnover of 2.75 can be compared against companies in the Healthcare Providers & Services industry. The industry median Receivables Turnover is 7.69. Relevium Technologies' value of 2.75 is 64.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.69, based on 656 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Relevium Technologies's current Receivables Turnover of 2.75 is 64.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Relevium Technologies and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Relevium Technologies's current Receivables Turnover is 2.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Relevium Technologies stock overvalued right now?
Relevium Technologies (RLLVF) has a current Receivables Turnover of 2.75. The current Receivables Turnover is 2.75 and 64.2% below the Healthcare Providers & Services industry median of 7.69. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Relevium Technologies (RLLVF), the current Receivables Turnover is 2.75 as of Mar. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Relevium Technologies Inc is a Canada based company operates in the health and wellness industry with a primary focus on online distribution. The principal business of the Company is the identification, evaluation, acquisition, and operations of brands and businesses in the health and wellness markets including medical cannabis. Its operating segment includes Consumer Packaged Goods (CPG); Pediatric Biopharma and Corporate. The company generates maximum revenue from Consumer Packaged Goods segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RLLVF has been successfully added to your 